Henkel AG & Co. KGaA vz. (Pref Shares)

May 6, 2021 (Q1 2021)

Group Q1 organic sales rose 7.7%. Henkel raised FY 2021 guidance to organic sales of 4–6%, adjusted EBIT margin of 14.0–15.0% and EPS growth in the high single-digit to mid-teens range [12]. Investors read early 2021 performance as evidence of post-COVID demand recovery and pricing power, shifting perception toward a resilient growth story after the pandemic trough [12].

H1 2021 (Aug 12, 2021)

Half-year 2021 results showed organic sales up 11.3% (approximately €10bn year-to-date) and operating profit of €1,430m, up 20.1%. Adjusted EBIT margin reached 14.4%. Henkel raised FY sales guidance to 6.0–8.0% with earnings guidance essentially confirmed [13]. Momentum confirmation reinforced the "Purposeful Growth" narrative as investors interpreted the combination of volumes, pricing and cost action as durable recovery execution [13].

Jan 28, 2022

Management announced a merger of Laundry & Home Care and Beauty Care into one Consumer Brands platform and lifted mid- and long-term organic sales target to 3–4%. The market viewed this as portfolio simplification to drive scale and premiumisation, positioning it as a strategic enabler for higher sustainable top-line growth versus prior targets [53].

Feb 23, 2022 (FY 2021 publication)

FY 2021 results showed sales of €20.1bn with organic growth of 7.8%. Adjusted EBIT reached approximately €2.7bn and adjusted EPS was €4.56, while free cash flow hit €1.5bn. Management announced integration steps, a share buyback program of up to €1bn, Venture Fund II of €150m and strengthened sustainability ambition for 2030 and beyond [11], [9]. The Purposeful Growth agenda gained credibility as investors began pricing in a combination of structural growth initiatives and explicit capital return through buyback—narrative shifting toward a disciplined compounder [11], [9].

FY 2022 (results announced Mar 7, 2023)

Group sales reached €22.4bn with organic growth of 8.8%, largely price-driven. Adjusted EBIT fell to €2.3bn (down 13.7%) and adjusted EBIT margin compressed to 10.4%, a decline of 3.0 percentage points. EPS was €3.90. Management set 2023 guidance conservatively at organic growth of 1–3% and adjusted EBIT margin of 10–12% [17]. The market grew concerned that top-line growth was driven by pricing while margins compressed from raw material and logistics inflation, raising questions about earnings quality and growth sustainability [17], [48].

Apr 2023

Henkel completed or announced the sale of its Russia business and signalled it would record a net financial loss from the transaction [56]. While the geopolitical and ESG alignment was generally welcomed, investors noted a one-off financial hit and near-term EPS uncertainty from the disposal [56].

Aug 2023 (Q2 update)

After Q2, Henkel lifted FY 2023 guidance to organic sales growth of 2.5–4.5% and adjusted EBIT margin of 11.0–12.5%, reflecting pricing and cost management [51]. This reinforced the turnaround narrative as analysts upgraded estimates and investor sentiment improved with accumulating evidence of margin restoration [51].

FY 2023 (publication Mar 4, 2024)

FY 2023 results showed sales of €21.5bn with organic growth of 4.2%. Adjusted EBIT reached €2,556m, up 10.2%, with adjusted EBIT margin of 11.9%. Adjusted EPS was €4.35, up 20%, and free cash flow hit €2,603m. The net financial position improved to approximately €12m. Henkel completed its first share buyback program [14], [16]. Proof of profitability and cash-flow recovery shifted investor view from value-trap to recovery/compounder, as balance-sheet repair and FCF generation supported confidence in capital returns and M&A optionality [14], [16].

FY 2024 (publication Mar 11, 2025)

FY 2024 results were described as "very good": sales of €21.6bn with organic growth of 2.6%. EBIT reached €3.1bn, up 20.9%, with adjusted EBIT margin of 14.3%. Adjusted EPS was €5.36, up 25.1%, and FCF reached €2.4bn. Management proposed a dividend increase (preferred €2.04, up 10.3%) and launched a new share buyback program of up to €1bn [5]. Strong margin recovery and explicit shareholder returns solidified a re-rating as investors rewarded execution on Purposeful Growth and capital allocation [5].

May 9–12, 2025 (program launch / start)

The new share buyback program of up to €1bn was launched (preferred approximately €800m, ordinary approximately €200m). Program execution started via stock exchange on May 12, 2025 and was scheduled to run until March 31, 2026 at the latest [6], [2]. The market welcomed renewed capital-return discipline, viewing the buyback as EPS-accretive and supportive to valuation ahead of strategic M&A deployment [6], [2].

May 12, 2025 – Mar 24, 2026 (execution period)

Henkel repurchased preferred shares with a total value of €795m and ordinary shares worth €198m. EQS notices show 10,728,935 preferred and 2,800,835 ordinary shares acquired by Feb 13, 2026 [2], [7]. Execution confirmed management's capital-return credibility and delivered measurable EPS support ahead of the M&A-driven strategic pivot [2], [7].

Jan 16, 2026

Henkel announced or closed the acquisition of ATP Adhesive Systems, the first tranche of the 2026 M&A push into adhesive capabilities [33]. This was seen as a targeted bolt-on to strengthen Adhesive Technologies, with investors beginning to reposition the company from margin recovery to growth via M&A [33].

Feb 4, 2026

Henkel agreed to acquire specialty-coatings company Stahl for €2.1bn enterprise value. The transaction strengthens Adhesive Technologies and coatings adjacency, subject to consultations and regulatory approvals [40], [42]. The market acknowledged a meaningful step to broaden industrial solutions exposure, viewed as positive for the long-term growth profile though raising integration and financing scrutiny in the near term [40], [42].

Mar 9, 2026

Henkel acquired Not Your Mother's, a haircare and styling brand, as part of the Consumer Brands M&A push [33]. This provided further evidence that Henkel was actively expanding its premium haircare footprint in North America, with investors beginning to view a concerted premium haircare build-out as a material strategic shift [33].

Mar 26, 2026

Henkel announced a definitive agreement to acquire OLAPLEX for $1.4bn, with an offer of $2.06 per share approved by the Olaplex board, subject to customary closing and regulatory approvals [28], [29], [30]. The market reaction split between appreciation of the strategic logic (premium haircare, DTC and retail reach) and concerns about deal premium and integration execution. The event created headline volatility but positioned Henkel for accelerated Consumer Brands growth [28], [29], [30].

May 7, 2026 (Q1 2026)

Q1 2026 results showed group sales of approximately €5.0bn with organic growth of 1.7% (volumes recovered). Management presented five signed M&A transactions worth approximately €1.6bn in sales, with three already closed (Wetherby Laroc, ATP Adhesive Systems, Not Your Mother's). Henkel reported the €1bn buyback program was successfully completed by end-March. FY 2026 outlook remained unchanged at organic growth of 1–3% and adjusted ROS of 14.5–16.0% [21], [25], [3]. Investors interpreted Q1 as a proof point for combining operational recovery with an aggressive, deliberate M&A push, though headline M&A risk kept volatility elevated [21], [25], [3].

July 7, 2026

Henkel announced successful closing of the OLAPLEX acquisition after fulfillment of closing conditions. OLAPLEX was integrated into Henkel Consumer Brands [27]. The closing removed a major execution overhang, allowing investors to focus on integration and synergies with perception tilted more positively provided integration meets targets [27].